Muscle News and Research

RSS

Seven-day exercise plan for reducing cancer risk

Being active for at least 30 minutes every day reduces your risk of developing some types of cancer. Fitness experts at The University of Texas M. D. Anderson Cancer Center have designed an exclusive exercise plan based on this evidence that will fit into almost anyone's lifestyle.

9 Feb 2010

Journal highlights toxic nature of herbal medicines

A University of Adelaide forensic pathologist has sounded a worldwide warning of the potential lethal dangers of herbal medicines if taken in large quantities, injected, or combined with prescription drugs.

9 Feb 2010

The Obama health summit: More reactions, details emerge

The Associated Press/Washington Post reports on Republicans' "chilly reception Monday to President Barack Obama's invitation to discuss health care in a bipartisan, televised setting later this month, part of the White House effort to revive the stalled legislation."

8 Feb 2010

Saint Louis University offers strategies for accomplishing goals

Olympic athletes inspire us with their fierce discipline and natural talent as they smash records, going higher, further and faster. Their can-do spirit encourages us all to take on new challenges.

6 Feb 2010

Athlete hopes for first U.S. cross-country medal; health issues plagued 2006 Olympic bid

Kris Freeman is back in the hunt for an Olympic medal in Vancouver after being named today to the U.S. ski team following a disappointing finish at the 2006 Games in Torino, Italy.

6 Feb 2010

Tβ4 may help treat skeletal muscle disease in Duchenne muscular dystrophy

REGENERX BIOPHARMACEUTICALS, INC. announced today that a research team in Washington, D.C. has found that dystrophin-deficient Mdx mice, treated twice a week for six months with Tβ4, showed a significant increase in skeletal muscle regenerating fibers compared to untreated mice. No effects related to muscle function or fibrosis and no adverse reactions were observed in the mice.

6 Feb 2010

Biotechnology: The next medical revolution

A recent article in the Scandia Journal reported that biotechnology is helping to improve our knowledge of many devastating illnesses, and has armed patients and their doctors with exciting new diagnostics and treatments to battle disease.

5 Feb 2010

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

Cardiologists and heart imaging specialists at 15 medical centers in eight countries, and led by researchers at Johns Hopkins, have enrolled the first dozen patients in a year-long investigation to learn whether the subtle squeezing of blood flow through the inner layers of the heart is better than traditional SPECT nuclear imaging tests and other diagnostic radiology procedures for accurately tracking the earliest signs of coronary artery clogs.

5 Feb 2010

HSS supports Arthritis Foundation's educational campaign for osteoarthritis

Hospital for Special Surgery, (HSS), a world leader in orthopedics and rheumatology, today announced its support of the Arthritis Foundation and Ad Council newly launched campaign, "Moving is the Best Medicine," to raise awareness of osteoarthritis, increase public health education and support breakthrough research.

5 Feb 2010

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

Bioheart, Inc., announced today that the company has commenced work on its REGEN trial, a Phase I Clinical Trial to test genetically modified MyoCell® in patients suffering from Congestive Heart Failure (CHF). Bioheart’s MyoCell® is a regenerative cell therapy that uses myoblasts, or muscle stem cells,that are grown from a patient’s own muscle. MyoCell® has been tested successfully on patients in four clinical trials.

5 Feb 2010

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

St. Jude Medical, Inc. today announced European CE Mark approval and first implants of its Fortify™ and Fortify ST implantable cardioverter defibrillators (ICD) and Unify™ cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S. versions of the Fortify ICD and Unify CRT-D are expected to be launched later this year. The reduced size of these new devices compared to those of previous generations creates the smallest available device footprint in the industry.

5 Feb 2010

Results from three phase two studies show the effectiveness of Tanezumab

Tanezumab, a humanized monoclonal antibody that targets nerve-growth factor, reduced pain in three common pain conditions, according to the results from three phase two studies presented today in a single poster at the American Academy of Pain Medicine's 26th Annual Meeting.

4 Feb 2010

Muscle Flex to issue 3,666,666 shares of restricted stock to Danny Alex for $110,000.00 investment

Muscle Flex Inc. (www.MuscleFlex.com) announced today that its CEO, Danny Alex, has made an additional investment of $110,000.00 into Muscle Flex Inc. by way of a direct investment for restricted stock at a share price of $0.03.

4 Feb 2010

Paracetamol reduces damage caused to kidneys following severe muscle injury

The commonly-used painkiller Paracetamol can protect against kidney failure after severe muscle injury, according to research at the University of Essex.

4 Feb 2010

Mapping of human genome modification during embryonic development

Scientists at The Genome Institute of Singapore (GIS) and The Scripps Research Institute (TSRI) led an international effort to build a map that shows in detail how the human genome is modified during embryonic development.

4 Feb 2010

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

A recent analysis of two pivotal clinical trials in patients with acute low back pain (ALBP) who were treated with SOMA® (carisoprodol) 250 mg showed significantly improved functionality and reduced disability after three days of treatment, as measured by the Roland-Morris Disability Questionnaire (RMDQ).

4 Feb 2010

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

3 Feb 2010

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Experts from the University of Pennsylvania School of Medicine are available to offer expert medical insight and commentary during the 2010 Winter Olympics in Vancouver on issues ranging from the effects of performance enhancing drugs to concerns about the spread of novel H1N1, head trauma and more.

3 Feb 2010

Bionanomotors can be used some day to move and manipulate molecules at nanoscale

A group of Marshall University researchers and their colleagues in Japan are conducting research that may lead to new ways to move or position single molecules-a necessary step if man someday hopes to build molecular machines or other devices capable of working at very small scales.

3 Feb 2010

New 3D scaffold for stem cell renewal

Medical researchers were shocked to discover that virtually all human embryonic stem cell lines being used in 2005 were contaminated. Animal byproducts used to line Petri dishes had left traces on the human cells. If those cells had been implanted in a human body they likely would have been rejected by the patient's immune system.

3 Feb 2010

Muscle News and Research

Seven-day exercise plan for reducing cancer risk

Journal highlights toxic nature of herbal medicines

The Obama health summit: More reactions, details emerge

Saint Louis University offers strategies for accomplishing goals

Athlete hopes for first U.S. cross-country medal; health issues plagued 2006 Olympic bid

Tβ4 may help treat skeletal muscle disease in Duchenne muscular dystrophy

Biotechnology: The next medical revolution

Tracking early signs of coronary artery clogs: CT perfusion vs. SPECT nuclear imaging tests

HSS supports Arthritis Foundation's educational campaign for osteoarthritis

Bioheart initiates REGEN Phase I Clinical Trial for testing genetically modified MyoCell in CHF patients

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

Results from three phase two studies show the effectiveness of Tanezumab

Muscle Flex to issue 3,666,666 shares of restricted stock to Danny Alex for $110,000.00 investment

Paracetamol reduces damage caused to kidneys following severe muscle injury

Mapping of human genome modification during embryonic development

Recent clinical trials in patients with ALBP show that SOMA 250 mg reduces disability

Major study of perfusion imaging under way to assess value of alternative diagnostic methods

Penn Medicine experts available to offer medical insight and commentary during 2010 Winter Olympics

Bionanomotors can be used some day to move and manipulate molecules at nanoscale

New 3D scaffold for stem cell renewal

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News